Low grade serous ovarian carcinoma: identifying variations in practice patterns.

Area of Science:

• Gynecologic Oncology
• Medical Practice Patterns
• Ovarian Cancer Subtypes

Background:

• Low-grade serous ovarian carcinoma (LGSOC) is a rare ovarian cancer subtype with a slow-growing and chemotherapy-resistant nature.
• Existing treatment strategies for LGSOC are not uniformly established, leading to variability in clinical practice.

Purpose of the Study:

• To investigate and identify variations in treatment strategies employed by physicians managing LGSOC.
• To understand current practice patterns in the management of both primary and recurrent LGSOC.

Main Methods:

• A survey was distributed to members of the Society of Gynecologic Oncology.
• The survey included questions on physician demographics, management of primary and recurrent disease, and use of consolidation therapy.
• Data were analyzed using chi-squared and Fisher's exact tests.

Main Results:

• 194 gynecologic oncologists responded, with most practicing in university settings and treating high volumes of ovarian cancer.
• Significant variations were observed in treatment preferences for primary disease based on debulking status.
• For recurrent disease, secondary cytoreduction was favored for platinum-sensitive recurrence, while hormone antagonism and BRAF inhibitors were preferred for platinum-resistant recurrence, depending on specific mutations.

Conclusions:

• There is considerable heterogeneity in the management of LGSOC among practitioners.
• Further research and guideline development are crucial to optimize treatment and improve outcomes for LGSOC patients.